These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors. Dayam R, Sanchez T, Clement O, Shoemaker R, Sei S, Neamati N. J Med Chem; 2005 Jan 13; 48(1):111-20. PubMed ID: 15634005 [Abstract] [Full Text] [Related]
4. Mining the NCI antiviral compounds for HIV-1 integrase inhibitors. Deng J, Kelley JA, Barchi JJ, Sanchez T, Dayam R, Pommier Y, Neamati N. Bioorg Med Chem; 2006 Jun 01; 14(11):3785-92. PubMed ID: 16460953 [Abstract] [Full Text] [Related]
5. Discovery of HIV-1 integrase inhibitors by pharmacophore searching. Hong H, Neamati N, Wang S, Nicklaus MC, Mazumder A, Zhao H, Burke TR, Pommier Y, Milne GW. J Med Chem; 1997 Mar 14; 40(6):930-6. PubMed ID: 9083481 [Abstract] [Full Text] [Related]
7. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase. Ma K, Wang P, Fu W, Wan X, Zhou L, Chu Y, Ye D. Bioorg Med Chem Lett; 2011 Nov 15; 21(22):6724-7. PubMed ID: 21996518 [Abstract] [Full Text] [Related]
8. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors. Kuo CL, Assefa H, Kamath S, Brzozowski Z, Slawinski J, Saczewski F, Buolamwini JK, Neamati N. J Med Chem; 2004 Jan 15; 47(2):385-99. PubMed ID: 14711310 [Abstract] [Full Text] [Related]
10. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase. Verschueren WG, Dierynck I, Amssoms KI, Hu L, Boonants PM, Pille GM, Daeyaert FF, Hertogs K, Surleraux DL, Wigerinck PB. J Med Chem; 2005 Mar 24; 48(6):1930-40. PubMed ID: 15771437 [Abstract] [Full Text] [Related]
11. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication. King PJ, Ma G, Miao W, Jia Q, McDougall BR, Reinecke MG, Cornell C, Kuan J, Kim TR, Robinson WE. J Med Chem; 1999 Feb 11; 42(3):497-509. PubMed ID: 9986720 [Abstract] [Full Text] [Related]
15. Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore. Deng J, Sanchez T, Al-Mawsawi LQ, Dayam R, Yunes RA, Garofalo A, Bolger MB, Neamati N. Bioorg Med Chem; 2007 Jul 15; 15(14):4985-5002. PubMed ID: 17502148 [Abstract] [Full Text] [Related]
16. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors. Pace P, Spieser SA, Summa V. Bioorg Med Chem Lett; 2008 Jul 15; 18(14):3865-9. PubMed ID: 18595690 [Abstract] [Full Text] [Related]
18. Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity. Li H, Wang C, Sanchez T, Tan Y, Jiang C, Neamati N, Zhao G. Bioorg Med Chem; 2009 Apr 01; 17(7):2913-9. PubMed ID: 19269185 [Abstract] [Full Text] [Related]
19. Design, synthesis, and anti-integrase activity of catechol-DKA hybrids. Maurin C, Bailly F, Mbemba G, Mouscadet JF, Cotelle P. Bioorg Med Chem; 2006 May 01; 14(9):2978-84. PubMed ID: 16412645 [Abstract] [Full Text] [Related]
20. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors. Kawasuji T, Fuji M, Yoshinaga T, Sato A, Fujiwara T, Kiyama R. Bioorg Med Chem; 2006 Dec 15; 14(24):8420-9. PubMed ID: 17005407 [Abstract] [Full Text] [Related] Page: [Next] [New Search]